4th ADC Analytical Development Summit 2025

 

The 4th ADC Analytical Development Summit (April 28-30, 2025 | Boston, MA) introduces a renewed focus on refining analytical techniques to meet the evolving demands of ADC development.

As regulatory expectations rise and product complexity increases, the summit will offer actionable insights to enhance existing methodologies. Sessions will cover a wide range of topics, including optimizing DAR quantification, improving aggregation analysis, and refining impurity profiling, presented by leading experts from AstraZeneca, AbbVie, Sutro Biopharma, Merck, Genentech, ADC Therapeutics, and more.

These discussions are designed to equip attendees with the precise tools necessary to develop robust, high-quality ADC products.

This is your chance to refine your analytical strategies, ensure compliance, and deliver safe, effective ADC products to patients in need.

Date of the summit – April 28-30, 2025

Find out more here…

More Info

---

---